<DOC>
	<DOC>NCT01728103</DOC>
	<brief_summary>The objective of this study is to obtain female first-catch urine, vaginal, cervical and endocervical swabs for testing with multiple APTIMA Assays on the Gen-Probe PANTHER® and TIGRIS® Systems.</brief_summary>
	<brief_title>Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Gonorrhea</mesh_term>
	<mesh_term>Trichomonas Infections</mesh_term>
	<mesh_term>Chlamydia Infections</mesh_term>
	<criteria>The subject is at least 16 years of age at the time of enrollment and is currently sexually active (has had penile/vaginal intercourse within the past 12 months) The subject and/or legally authorized representative is willing to undergo the informed consent process prior to study participation (a minor will need the documented consent of his/her parent or legal guardian, unless the site has an institutional review board [IRB]approved waiver for parental consent for minors) In addition, the subject must meet at least one of the following criteria: The subject reports symptoms consistent with a suspected sexually transmissible infection (STI) such as abnormal discharge, genital itching, pain/discomfort during sexual intercourse or urination, and/or lower abdominal discomfort Subject is asymptomatic and known to be partners with, or a contact of, a person with a confirmed or suspected STI(s) Subject is asymptomatic and undergoing screening evaluation for possible STIs Subject is asymptomatic and undergoing a routine examination with a pelvic examination The subject took antibiotic medications within the last 21 days Subject already participated in this study Subject has a history of illness that the principal investigator (PI) or designee considers could interfere with or affect the conduct, results, and/or completion of the clinical trial Subject has a history of illness that the PI or designee considers could create an unacceptable risk to the subject if enrolled</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>